Abstract
Recent genome-wide association studies (GWAS) have identified several novel single nucleotide polymorphisms (SNPs) associated with type 2 diabetes (T2D). Various models using clinical and/or genetic risk factors have been developed for T2D risk prediction. However, analysis considering algorithms for genetic risk factor detection and regression methods for model construction in combination with interactions of risk factors has not been investigated. Here, using genotype data of 7,360 Japanese individuals, we investigated risk prediction models, considering the algorithms, regression methods and interactions. The best model identified was based on a Bayes factor approach and the lasso method. Using nine SNPs and clinical factors, this method achieved an area under a receiver operating characteristic curve (AUC) of 0.8057 on an independent test set. With the addition of a pair of interaction factors, the model was further improved (p-value 0.0011, AUC 0.8085). Application of our model to prospective cohort data showed significantly better outcome in disease-free survival, according to the log-rank trend test comparing Kaplan-Meier survival curves (p-value2:09 × 10-11). While the major contribution was from clinical factors rather than the genetic factors, consideration of genetic risk factors contributed to an observable, though small, increase in predictive ability. This is the first report to apply risk prediction models constructed from GWAS data to a T2D prospective cohort. Our study shows our model to be effective in prospective prediction and has the potential to contribute to practical clinical use in T2D.
| Original language | English |
|---|---|
| Article number | e92549 |
| Journal | PloS one |
| Volume | 9 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 20-03-2014 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)
- Agricultural and Biological Sciences(all)
- General
Cite this
}
The construction of risk prediction models using GWAS data and its application to a type 2 diabetes prospective cohort. / Shigemizu, Daichi; Abe, Testuo; Morizono, Takashi; Johnson, Todd A.; Boroevich, Keith A.; Hirakawa, Yoichiro; Ninomiya, Toshiharu; Kiyohara, Yutaka; Kubo, Michiaki; Nakamura, Yusuke; Maeda, Shiro; Tsunoda, Tatsuhiko.
In: PloS one, Vol. 9, No. 3, e92549, 20.03.2014.Research output: Contribution to journal › Article
TY - JOUR
T1 - The construction of risk prediction models using GWAS data and its application to a type 2 diabetes prospective cohort
AU - Shigemizu, Daichi
AU - Abe, Testuo
AU - Morizono, Takashi
AU - Johnson, Todd A.
AU - Boroevich, Keith A.
AU - Hirakawa, Yoichiro
AU - Ninomiya, Toshiharu
AU - Kiyohara, Yutaka
AU - Kubo, Michiaki
AU - Nakamura, Yusuke
AU - Maeda, Shiro
AU - Tsunoda, Tatsuhiko
PY - 2014/3/20
Y1 - 2014/3/20
N2 - Recent genome-wide association studies (GWAS) have identified several novel single nucleotide polymorphisms (SNPs) associated with type 2 diabetes (T2D). Various models using clinical and/or genetic risk factors have been developed for T2D risk prediction. However, analysis considering algorithms for genetic risk factor detection and regression methods for model construction in combination with interactions of risk factors has not been investigated. Here, using genotype data of 7,360 Japanese individuals, we investigated risk prediction models, considering the algorithms, regression methods and interactions. The best model identified was based on a Bayes factor approach and the lasso method. Using nine SNPs and clinical factors, this method achieved an area under a receiver operating characteristic curve (AUC) of 0.8057 on an independent test set. With the addition of a pair of interaction factors, the model was further improved (p-value 0.0011, AUC 0.8085). Application of our model to prospective cohort data showed significantly better outcome in disease-free survival, according to the log-rank trend test comparing Kaplan-Meier survival curves (p-value2:09 × 10-11). While the major contribution was from clinical factors rather than the genetic factors, consideration of genetic risk factors contributed to an observable, though small, increase in predictive ability. This is the first report to apply risk prediction models constructed from GWAS data to a T2D prospective cohort. Our study shows our model to be effective in prospective prediction and has the potential to contribute to practical clinical use in T2D.
AB - Recent genome-wide association studies (GWAS) have identified several novel single nucleotide polymorphisms (SNPs) associated with type 2 diabetes (T2D). Various models using clinical and/or genetic risk factors have been developed for T2D risk prediction. However, analysis considering algorithms for genetic risk factor detection and regression methods for model construction in combination with interactions of risk factors has not been investigated. Here, using genotype data of 7,360 Japanese individuals, we investigated risk prediction models, considering the algorithms, regression methods and interactions. The best model identified was based on a Bayes factor approach and the lasso method. Using nine SNPs and clinical factors, this method achieved an area under a receiver operating characteristic curve (AUC) of 0.8057 on an independent test set. With the addition of a pair of interaction factors, the model was further improved (p-value 0.0011, AUC 0.8085). Application of our model to prospective cohort data showed significantly better outcome in disease-free survival, according to the log-rank trend test comparing Kaplan-Meier survival curves (p-value2:09 × 10-11). While the major contribution was from clinical factors rather than the genetic factors, consideration of genetic risk factors contributed to an observable, though small, increase in predictive ability. This is the first report to apply risk prediction models constructed from GWAS data to a T2D prospective cohort. Our study shows our model to be effective in prospective prediction and has the potential to contribute to practical clinical use in T2D.
UR - http://www.scopus.com/inward/record.url?scp=84898629887&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898629887&partnerID=8YFLogxK
U2 - 10.1371/journal.pone.0092549
DO - 10.1371/journal.pone.0092549
M3 - Article
C2 - 24651836
AN - SCOPUS:84898629887
VL - 9
JO - PLoS One
JF - PLoS One
SN - 1932-6203
IS - 3
M1 - e92549
ER -